Hung Trinh: Shared Peptide Vaccine Candidates in Ovarian Cancer

Hung Trinh

Diego A Díaz García: Addressing the Rising Global Burden of Renal Cancer

Diego A Díaz García: Addressing the Rising Global Burden of Renal Cancer

George Kumar: FL is Not a Single Disease Entity, But a Spectrum of Molecularly Distinct Subtypes

George Kumar

Mostafa Faisal Shared Study on HLA-DQB1 Mismatch and Donor Age in HCT Outcomes

Mostafa Faisal Shared Study on HLA-DQB1 Mismatch and Donor Age in HCT Outcomes

Patrick Hwu Highlights Promising Results from AMPLIFY-201 trial

Colorectal Cancer

Jarushka Naidoo: Excellent Talk from Bingnan Zhang on CNS Activity in BiTES and ADCs

Jarushka Naidoo: Excellent Talk from Bingnan Zhang on CNS Activity in BiTES and ADCs

Drugs

Patrick Soon-Shiong

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter
Patrick Soon-Shiong
MARIPOSA

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

MARIPOSA
pembrolizumab sBLA FDA approval

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

pembrolizumab sBLA FDA approval
tebetafusp kimmtrak

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

tebetafusp kimmtrak
FDA

U.S. FDA Approval of Ziihera for the Previously Treated, Unresectable or IHC 3+ Biliary Tract Cancer

FDA
FDA

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

FDA
FDA

FDA approves Novocure’s treatment for mNSCLC

FDA
Patrick Soon-Shiong

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Patrick Soon-Shiong
Dana Dornsife

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding
Matt Sherer

Matt Sherer: ASCO Supports Permanent Medicare Telehealth
FDA PreCheck

New FDA PreCheck Program to Boost U.S. Drug Manufacturing